Lupus Foundation of America4 小时
Investigator-initiated Study of CNTY-101, for People with Autoimmune Diseases, Including ...
An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of ...
Personalized therapy for rare genetic diseases: Patient-derived organoids offer new hope
Children's Mercy Kansas City has achieved a significant advancement toward the treatment of rare genetic diseases through the ...